Antioxidant drugs for treating beta-cell oxidative stress in type 2 diabetes: glucose-centric versus insulin-centric therapy
- PMID: 20193639
Antioxidant drugs for treating beta-cell oxidative stress in type 2 diabetes: glucose-centric versus insulin-centric therapy
Abstract
Mainstays of therapy for type 2 diabetes involve drugs that are insulin-centric, i.e., they are designed to increase insulin secretion and decrease insulin resistance. The usual clinical course for people so treated is to have initially improved glycemic control but over time a need for intensification of drug-based treatment of hyperglycemia. The mechanism for this unrelenting deterioration of beta-cell function is related to chronic oxidative stress. This suggests that drug discovery should not exclusively focus on insulin-centric _targets, but also include glucose-centric strategies, such as antioxidant protection of the beta-cell. This may facilitate repair of beta-cells undergoing damage by oxidative stress secondary to chronic hyperglycemia.
Similar articles
-
Protection of pancreatic beta-cells: is it feasible?Nutr Metab Cardiovasc Dis. 2008 Jan;18(1):74-83. doi: 10.1016/j.numecd.2007.05.004. Nutr Metab Cardiovasc Dis. 2008. PMID: 18096375 Review.
-
Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.Pancreas. 2007 Nov;35(4):e10-7. doi: 10.1097/mpa.0b013e318150e4f2. Pancreas. 2007. PMID: 18090226
-
Beta-cell function and mass in type 2 diabetes.Dan Med Bull. 2009 Aug;56(3):153-64. Dan Med Bull. 2009. PMID: 19728971
-
Diabetes, glucose toxicity, and oxidative stress: A case of double jeopardy for the pancreatic islet beta cell.Free Radic Biol Med. 2006 Jul 15;41(2):177-84. doi: 10.1016/j.freeradbiomed.2005.04.030. Epub 2006 May 4. Free Radic Biol Med. 2006. PMID: 16814095 Review.
-
Oxidative stress--mediated alterations in glucose dynamics in a genetic animal model of type II diabetes.Life Sci. 2005 Sep 30;77(20):2552-73. doi: 10.1016/j.lfs.2005.01.033. Life Sci. 2005. PMID: 15936776
Cited by
-
Investigation of Pancreatic-beta Cells Role in the Biological Process of Ageing.Endocr Metab Immune Disord Drug _targets. 2024;24(3):348-362. doi: 10.2174/1871530323666230822095932. Endocr Metab Immune Disord Drug _targets. 2024. PMID: 37608675 Review.
-
β-cell dysfunction: Its critical role in prevention and management of type 2 diabetes.World J Diabetes. 2015 Feb 15;6(1):109-24. doi: 10.4239/wjd.v6.i1.109. World J Diabetes. 2015. PMID: 25685282 Free PMC article. Review.
-
Group VIB Phospholipase A(2) promotes proliferation of INS-1 insulinoma cells and attenuates lipid peroxidation and apoptosis induced by inflammatory cytokines and oxidant agents.Oxid Med Cell Longev. 2012;2012:989372. doi: 10.1155/2012/989372. Epub 2012 Nov 11. Oxid Med Cell Longev. 2012. PMID: 23213352 Free PMC article.
-
Glutathione peroxidase mimic ebselen improves glucose-stimulated insulin secretion in murine islets.Antioxid Redox Signal. 2014 Jan 10;20(2):191-203. doi: 10.1089/ars.2013.5361. Epub 2013 Aug 9. Antioxid Redox Signal. 2014. PMID: 23795780 Free PMC article.
-
Analysis of an antioxidative defence system of hydrogen peroxide-treated pancreatic islet-derived 1.1B4 cells and siRNA _targeting NR4A3-treated cells by microarray.Redox Rep. 2023 Dec;28(1):2247150. doi: 10.1080/13510002.2023.2247150. Redox Rep. 2023. PMID: 37581334 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical